The AKT Axis as a Therapeutic Target in Autoimmune Diseases

Publisher： Bentham Science Publishers

E-ISSN： 2212-3873|9|2|145-150

ISSN： 1871-5303

Source： Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.9, Iss.2, 2009-06, pp. : 145-150

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

B cells as a therapeutic target in autoimmune diseases

By Park Yong Wook   Pryshchep Sergey   Seyler Thorsten M   Goronzy Jörg J   Weyand Cornelia M  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 3, 2005-06 ,pp. : 431-445

Informa Healthcare

Access to resources Recommend Favorite

Akt as a therapeutic target in cancer

By Steelman Linda S   Stadelman Kristin M   Chappell William H   Horn Stefan   Bäsecke Jörg   Cervello Melchiorre   Nicoletti Ferdinando   Libra Massimo   Stivala Franca   Martelli Alberto M   McCubrey James A  

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 9, 2008-09 ,pp. : 1139-1165

Informa Healthcare

Access to resources Recommend Favorite

The Interleukin-17/Interleukin-22 Innate Axis in the Gut as a New Drug Target in Allergic-Inflammatory and Autoimmune Diseases. A Working Hypothesis

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 14, Iss. 2, 2014-06 ,pp. : 145-151

Bentham Science Publishers

Access to resources Recommend Favorite

Modern Therapeutic Strategies for Autoimmune Diseases

By  

Current Pharmaceutical Design, Vol. 18, Iss. 29, 2012-10 ,pp. : 4508-4512

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Monitoring of Immunotherapies in Autoimmune Diseases

By  

Current Pharmaceutical Design, Vol. 18, Iss. 29, 2012-10 ,pp. : 4550-4555

Bentham Science Publishers

Access to resources Recommend Favorite